424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
First tracked pre-IPO filing for this issuer.
28,000,000 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker HCTI · Warrant exercisable at $0.00001 per share for 50,000 shares · Selling stockholders only · Use of proceeds Proceeds from the sale go to the selling stockholder; no proceeds to the company · Underwriters Hudson Global Ventures, LLC
2026-07-16 · 0001213900-26-078700
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
First tracked pre-IPO filing for this issuer.
2026-07-15 · 9999999995-26-002318
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
28,000,000 shares
Common Stock · Exchange Nasdaq · Ticker HCTI · ELOC Warrant exercisable at $0.00001 per share for 50,000 shares · Selling stockholders only · Use of proceeds To fund the ELOC Purchase Agreement · Underwriters Hudson Global Ventures, LLC
2026-07-10 · 0001213900-26-077268
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
First tracked pre-IPO filing for this issuer.
2026-07-09 · 0001213900-26-076690
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Gross proceeds $39,000,000
Common Stock · Exchange Nasdaq · Ticker HCTI · Underwriters Spartan Capital Securities, LLC
2026-03-31 · 0001213900-26-037401
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $5.81 · 421,553 shares · Gross proceeds $3,959,820
Common Stock · Exchange Nasdaq · Ticker HCTI · Pre-Funded Warrants to purchase 260,000 shares of common stock · Use of proceeds working capital · Flags warrants · Underwriters D. Boral Capital LLC
2026-02-27 · 0001213900-26-021235
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-12-19 · 9999999995-25-003861
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
1,458,118 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker HCTI · Common warrants issued to Warrant Inducement Holders and WallachBeth designees · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes
2025-11-25 · 0001213900-25-114840
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2025-11-24 · 9999999995-25-003365
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B4 and confirms the priced prospectus.
Gross proceeds $20,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker HCTI · Underwriters Spartan Capital Securities, LLC
2025-11-19 · 0001213900-25-112544
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
1,483,809,885 shares
Common Stock · Exchange Nasdaq · Ticker HCTI · Includes Series A and B warrants with exercise price reset provisions and zero exercise price options · Selling stockholders only · Use of proceeds Proceeds from selling stockholders' sales and potential cash exercises of warrants · Flags units, warrants
2025-05-15 · 0001213900-25-044095
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2025-05-14 · 9999999995-25-001597
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
1,483,809,885 shares
Common Stock · Exchange Nasdaq · Ticker HCTI · Units · Series A and Series B warrants with exercise price reset provisions and zero exercise price option for Series B · Selling stockholders only · Use of proceeds Proceeds from warrant exercises · Flags units, warrants
Healthcare Triangle, Inc. (HCTI) is offering up to 1,483,809,885 shares of common stock through selling stockholders, including shares from units, pre-funded warrants, and Series A/B warrants with complex exercise price reset provisions. The company is not directly selling shares or receiving proceeds from stockholder sales, but will collect cash from Purchase Warrant exercises. The offering is part of registration rights agreements, with no assurance of full sales. The stock is listed on Nasdaq under HCTI, with a recent closing price of $0.2996. Key risks include market uncertainty, warrant complexity, and reliance on third-party data.
2025-05-09 · 0001213900-25-041190
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
1,483,809,885 shares
Common Stock · Exchange Nasdaq · Ticker HCTI · Units consisting of Common Stock and Warrants · Includes Pre-funded Warrants, Series A Warrants, and Series B Warrants with exercise price resets and zero exercise price options · Selling stockholders only · Use of proceeds Proceeds from cash exercises of Purchase Warrants · Flags units, warrants
Healthcare Triangle, Inc. (HCTI) is registering up to 1,483,809,885 shares of common stock for resale by selling stockholders. The filing includes details about warrants (Purchase Warrants) with exercise price reset provisions, including a floor price of $0.084 per share and a zero exercise price option for Series B Warrants. The company emphasizes its focus on healthcare IT solutions in cloud services, data science, and managed services for EHR and life sciences sectors.
2025-04-22 · 0001213900-25-034248
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
1,483,809,885 shares
Common · Exchange Nasdaq · Ticker HCTI · Units consisting of common stock and warrants · Includes pre-funded warrants and Series A/B warrants with exercise price resets · Selling stockholders only · Use of proceeds Proceeds from warrant exercises · Flags units, warrants
Healthcare Triangle, Inc. (HCTI) is a healthcare information technology company offering cloud services, data science, and professional services. The company is registering up to 1.48 billion shares of common stock for sale by selling stockholders, including shares from units, pre-funded warrants, and Series A/B warrants. The offering is part of a registration statement under the Securities Act of 1933, with no direct proceeds to HCTI. The filing highlights the company's focus on healthcare IT solutions, including proprietary platforms like CloudEz and DataEz, and its reliance on third-party data sources. The company is an emerging growth company with no material impact from COVID-19, but risks include market adoption, competition, and stock volatility.
2025-04-01 · 0001213900-25-027277
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2024-02-13 · 9999999995-24-000420
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
12,183,612 shares
Common Stock · Exchange Nasdaq · Ticker HCTI · First Tranche Warrants exercisable for up to 1,072,500 shares · Selling stockholders only · Use of proceeds Selling stockholder will receive all proceeds; company does not receive any · Flags warrants, self_underwritten
Healthcare Triangle, Inc. reports a 35% revenue decline to $7.78 million for Q3 2023 compared to $11.95 million in Q3 2022, driven by reduced software services, managed services, and platform revenues. The company remains heavily reliant on top customers (78% of revenue in Q3 2023), with Customer 1 contributing $4.17 million. Financial performance shows net losses of $1.94 million in Q3 2023, with challenges in transitioning to subscription-based revenue models. The company highlights risks related to customer concentration, subscription adoption, and managed services margin pressures.
2024-02-12 · 0001213900-24-012305
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior EFFECT filing.
12,183,612 shares · Gross proceeds $6,579,150
Common Stock · Exchange Nasdaq · Ticker HCTI · First Tranche Warrants (up to 1,072,500 shares) · Selling stockholders only · Use of proceeds Selling stockholders will receive all proceeds from share sales · Flags warrants
Healthcare Triangle, Inc. focuses on generating recurring subscription revenue through SaaS offerings like DataEz, CloudEz, and Readabl.AI, but faces challenges in customer adoption and revenue diversification. Revenue declined 35% YoY in Q3 2023 due to reduced software services and managed services, with top 5 customers accounting for 78% of revenue. The company relies on existing clients for growth, while transitioning toward subscription models with lower margins. Financials show reduced R&D and marketing expenses but increased interest costs from short-term borrowings.
2024-02-09 · 0001213900-24-012185
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2024-01-31 · 9999999995-24-000267
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
12,183,612 shares
Common · Exchange Nasdaq · Ticker HCTI · Selling stockholders only · Use of proceeds Proceeds from the sale will go to the selling stockholder
Healthcare Triangle, Inc. filed an S-1 registration statement in 2024, highlighting its debt servicing capabilities, no material COVID-19 impact, and key growth factors like scaling investments, customer adoption, SaaS transition, and revenue mix. Financials show a 35% revenue decline in Q3 2023 vs. 2022, with top 5 customers contributing 78% of revenue. The company emphasizes recurring subscription revenue potential but notes challenges in SaaS adoption and customer retention. The filing also details revenue recognition methods, cost structures, and PPP loan details.
2024-01-12 · 0001213900-24-003418
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2022-08-22 · 9999999995-22-002466
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
12,621,951 shares
Common Stock · Exchange Nasdaq · Ticker HCTI · Selling stockholders only · Use of proceeds General corporate purposes
Healthcare Triangle, Inc. is registering 12,621,951 shares of common stock for resale by selling stockholders. The shares originate from a July 2022 private placement, warrants, preferred investment options, and placement agent compensation. The company will not receive proceeds from the resale but may from exercised options. The filing updates previous submissions with specific share details, registration numbers, and revised prospectus sections.
2022-08-18 · 0001607062-22-000525
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
12,621,951 shares · Gross proceeds $0.00
Common Stock · Exchange Nasdaq Capital Market · Ticker HCTI · Pre-Funded Warrants and Preferred Investment Options · Selling stockholders only · Use of proceeds Proceeds from exercise of warrants and preferred investment options for general corporate purposes
Healthcare Triangle, Inc. is registering 12,621,951 shares of common stock for resale by selling stockholders. The shares originate from a July 2022 private placement, warrants, preferred investment options, and placement agent compensation. The company will not receive proceeds from the resale but may benefit if warrants and options are exercised. The stock is listed on Nasdaq under HCTI, with risks including market volatility and unproven technology solutions.
2022-08-18 · 0001607062-22-000523
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 424B4.
Healthcare Triangle, Inc. is a healthcare information technology company providing cloud services, data science, and managed services to healthcare and life sciences organizations. The company is registering 12,621,951 shares of common stock for resale by selling stockholders, including shares from a recent private placement, warrants, and preferred investment options. Proceeds from certain exercises will be used for general corporate purposes. The stock is listed on Nasdaq under HCTI, with a recent closing price of $0.749699 as of August 8, 2022.
2022-08-09 · 0001607062-22-000491
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $4.00 · 4,709,255 shares · Gross proceeds $13,050,000
Common · Exchange NASDAQ · Ticker HCTI · Over-allotment 489,375 · Warrants exercisable at $2.88 per share · Use of proceeds Company will receive proceeds from warrant exercises but not from secondary selling stockholders · Underwriters EF HUTTON division of Benchmark Investments, LLC
Healthcare Triangle, Inc. is preparing for its IPO with a focus on expanding its SaaS offerings, which are set to launch in Q3 2021. The company highlights the impact of the COVID-19 pandemic on its operations, including shifts to remote work and reduced discretionary spending. Despite challenges, the company reported sequential revenue growth in 2020, with healthcare revenue recovering to pre-pandemic levels by Q4 2020. The company also received a $1.5M PPP loan, fully forgiven as of the filing date, which was recognized as other income. The narrative emphasizes the potential of SaaS to drive future revenue growth, though uncertainties remain regarding market competition and customer adoption.
2021-10-14 · 0001607062-21-000414
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2021-10-12 · 9999999995-21-003852
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows CERT and registers the class of securities for exchange listing.
2021-10-12 · 0001607062-21-000401
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2021-10-12 · 0001354457-21-001151
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Healthcare Triangle, Inc. filed a pre-effective amendment (S-1/A) to its registration statement for an initial public offering (IPO) of common stock. The filing includes updates to Exhibit 5.1 and references to prior amendments. The company plans to register 4,626,991 shares of common stock, with 3,333,334 shares offered by the company and 1,293,657 shares by selling stockholders. The offering price is assumed to be $4.50 per share, with proceeds intended for general corporate purposes. The parent company, SecureKloud Technologies, Inc., will retain significant ownership post-offering, and the company will be a controlled entity under Nasdaq rules.
2021-10-08 · 0001607062-21-000391
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $4.50 · Range $4.00 to $5.00 · 4,626,991 shares · Gross proceeds $20,821,460
Common Stock · Exchange Nasdaq Capital Market · Ticker HCTI · Over-allotment 500,000 · Warrants to purchase common stock at 72% and 110% of the public offering price, and convertible notes convertible at 60% of the public offering price · Use of proceeds Proceeds from warrant exercises will be received by the company; selling stockholders' shares are not part of the underwritten offering · Underwriters EF Hutton, division of Benchmark Investments, LLC
Healthcare Triangle, Inc. is conducting an initial public offering (IPO) of 3,333,334 shares of common stock, with additional shares offered by Selling Stockholders. The offering includes shares from convertible notes and warrants, with the parent company, SecureKloud Technologies, Inc., retaining significant ownership. The stock is slated for Nasdaq listing under HCTI, with an assumed offering price of $4.50 per share. The company emphasizes risks related to market volatility, lack of public trading history, and reliance on its parent company.
2021-10-07 · 0001607062-21-000388
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $5.00 · Range $4.50 to $5.50 · 9,184,438 shares · Gross proceeds $46,375,000
Common Stock, $0.00001 par value per share · Exchange Nasdaq · Ticker HCTI · Over-allotment 1,200,000 · Warrants to purchase common stock issued to underwriters (1.25% of shares) and selling stockholders (72% exercise price). Convertible note conversion at 60% of offering price. · Use of proceeds Proceeds from warrant exercises, if any, will be used for general corporate purposes. · Flags warrants · Underwriters EF Hutton, division of Benchmark Investments, LLC
Healthcare Triangle, Inc. is conducting an IPO of 9,184,438 shares of common stock, including 8,000,000 shares offered by the company and 1,184,438 shares offered by selling stockholders. The offering price is assumed to be $5.00 per share, with proceeds primarily going to selling shareholders. The parent company, SecureKloud Technologies, Inc., will retain 67.6% ownership post-offering. The company will receive proceeds only upon exercise of warrants held by selling stockholders. The IPO is subject to market risks, including lack of public trading history and volatility.
2021-09-30 · 0001607062-21-000373
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $5.00 · Range $4.50 to $5.50 · 9,184,438 shares · Gross proceeds $46,375,000
Common Stock, $0.00001 par value per share · Exchange Nasdaq Capital Market · Ticker HCTI · Over-allotment 1,200,000 · Underwriters receive warrants for 1.25% of shares at 110% of public price; selling stockholders receive warrants for 739,438 shares at 72% of public price · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes · Flags warrants · Underwriters EF HUTTON division of Benchmark Investments, LLC
Healthcare Triangle, Inc. is conducting an initial public offering (IPO) of 8,000,000 shares of common stock, with selling stockholders offering an additional 1,184,438 shares. The offering assumes a public price of $5.00 per share, with proceeds intended for the company and specific terms for warrants and convertible notes. The parent company, SecureKloud Technologies, Inc., will retain significant ownership, making Healthcare Triangle a controlled company under Nasdaq rules. The filing highlights risks related to market volatility, lack of public trading history, and dependence on parent company support.
2021-09-27 · 0001607062-21-000360
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Price $5.00 · Range $4.50 to $5.50 · 8,000,000 shares · Gross proceeds $40,000,000
Common Stock, $0.00001 par value per share · Exchange Nasdaq Capital Market · Ticker HCTI · Over-allotment 1,200,000 · Warrants to purchase common stock at 110% of the public offering price · Use of proceeds General corporate purposes, including debt repayment, working capital, and acquisitions · Flags warrants · Underwriters EF Hutton, division of Benchmark Investments, LLC
Healthcare Triangle, Inc. (HTI) is a healthcare information technology company offering cloud services, data science, and professional services to healthcare and life sciences organizations. The company is conducting an initial public offering (IPO) of 8,000,000 shares of common stock at an estimated price range of $4.50 to $5.50 per share, with a potential over-allotment option of 15%. The offering aims to raise up to $46 million for acquisitions, convertible note repayment, working capital, and general corporate purposes. HTI's parent company, SecureKloud Technologies, Inc., will retain approximately 67.6% ownership post-offering, making HTI a controlled company. The shares are expected to be listed on the Nasdaq Capital Market under the ticker symbol HCTI.
2021-09-10 · 0001607062-21-000326
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1 and supplements the active offering with updated prospectus details.
Range $4.50 to $5.50 · Gross proceeds $46,000,000
Shares of common stock · Exchange Nasdaq Capital Market · Ticker HCTI · Use of proceeds Acquisitions, convertible note repayment, working capital, and general corporate purposes · Underwriters EF Hutton, division of Benchmark Investments, LLC
Healthcare Triangle, Inc. is conducting an initial public offering (IPO) of 8,000,000 shares of common stock at an estimated price range of $4.50 to $5.50 per share, with gross proceeds up to $46 million. The company provides cloud infrastructure migration, AI, data analytics, and healthcare IT solutions, focusing on SaaS platforms like CloudEZ, DataEZ, and readabl.ai. The offering is underwritten by EF Hutton, and proceeds will be used for acquisitions, debt repayment, and general corporate purposes. The company operates in a competitive healthcare IT sector with risks including regulatory changes, cybersecurity threats, and reliance on third-party providers.
2021-09-09 · 0001607062-21-000320
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Price $5.00 · Range $4.50 to $5.50 · 8,000,000 shares · Gross proceeds $40,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker HCTI · Over-allotment 1,200,000 · Warrants to purchase common stock at 110% of the public offering price, equal to 8% of the shares issued · Use of proceeds Proceeds will be used for general corporate purposes · Flags warrants · Underwriters EF Hutton, division of Benchmark Investments, LLC
Healthcare Triangle, Inc. is conducting an initial public offering (IPO) of 8,000,000 shares of common stock at an assumed public offering price of $5.00 per share. The company, a healthcare information technology firm, focuses on cloud services, data science, and professional services for the healthcare and life sciences sectors. Upon completion of the offering, its parent company, SecureKloud Technologies, Inc., will own approximately 67.6% of outstanding shares. The IPO aims to list on the Nasdaq Capital Market under the symbol HCTI, with underwriters including EF Hutton, division of Benchmark Investments, LLC. The filing highlights risks related to lack of public market, dependence on parent company, and pandemic-related uncertainties.
2021-08-30 · 0001607062-21-000301
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Healthcare Triangle, Inc. is conducting an initial public offering (IPO) of [●] shares of common stock, with an expected public offering price of $[●] per share. The company, a healthcare information technology firm, focuses on cloud services, data science, and managed services for the healthcare and life sciences industry. Upon completion of the offering, its parent company, SecureKloud Technologies, Inc., will own approximately [●]% of outstanding shares. The IPO is conditional on Nasdaq Capital Market listing under the symbol HCTI, and the company is classified as an emerging growth company with reduced reporting requirements.
2021-07-23 · 0001607062-21-000238
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Healthcare Triangle, Inc. is conducting an initial public offering (IPO) of its common stock, with the goal of listing on the Nasdaq Capital Market under the symbol HCTI. The offering includes up to [●] shares, with the parent company, SecureKloud Technologies, Inc., retaining approximately [●]% ownership post-offering. The company focuses on healthcare IT solutions, including cloud services, data science, and managed services, and is transitioning some platforms to a SaaS model. The filing amends prior submissions to include updated underwriting terms and prospectus details.
2021-06-24 · 0001607062-21-000177
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Healthcare Triangle, Inc. is conducting an initial public offering (IPO) of its common stock, aiming to raise capital through the sale of up to a specified number of shares. The company provides healthcare IT solutions, including cloud services, data science, and managed services, targeting healthcare delivery organizations, insurers, and life sciences firms. The offering is underwritten by Kingswood Capital Markets, with the stock expected to be listed on the Nasdaq Capital Market under the symbol HCTI. The company is a controlled entity and an emerging growth company, subject to reduced reporting requirements.
2021-04-19 · 0001607062-21-000087